Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://tiannauxth787957.look4blog.com/76793882/retaglutide-a-promising-glp-1-receptor-agonist